| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Neurocalcin delta (NCALD), transcript variant 6 from ORIGENE TECHNOLOGIES | LY421788 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 8 from ORIGENE TECHNOLOGIES | LY410350 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 7 from ORIGENE TECHNOLOGIES | LY421789 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurocalcin delta (NCALD), transcript variant 7 from ORIGENE TECHNOLOGIES | LY425721 | 100 ug | ORIGENE TECHNOLOGIES |
| Neurochondrin (NCDN), transcript variant 1 from ORIGENE TECHNOLOGIES | LY423092 | 100 ug | ORIGENE TECHNOLOGIES |
| NEUROD2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN405293 | 1 kit | ORIGENE TECHNOLOGIES |
| NEUROD6 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407178 | 1 kit | ORIGENE TECHNOLOGIES |
| NEUROD4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN422464 | 1 kit | ORIGENE TECHNOLOGIES |
| NEUROD1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN401987 | 1 kit | ORIGENE TECHNOLOGIES |
| Neurod1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN510917 | 1 kit | ORIGENE TECHNOLOGIES |
| Neurod2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN510918 | 1 kit | ORIGENE TECHNOLOGIES |
| Neurod6 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN510920 | 1 kit | ORIGENE TECHNOLOGIES |
| NEUROD1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH301987 | 10 ug | ORIGENE TECHNOLOGIES |
| Neurod4 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN510919 | 1 kit | ORIGENE TECHNOLOGIES |
| Neuroepithelial cell transforming 1 (NET1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY425812 | 100 ug | ORIGENE TECHNOLOGIES |
| NEUROD2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH305293 | 10 ug | ORIGENE TECHNOLOGIES |
| Neuroepithelial cell transforming 1 (NET1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY401777 | 100 ug | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIES | CS626350 | 5x5um | ORIGENE TECHNOLOGIES |
| Neuroepithelial cell transforming 1 (NET1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY420761 | 100 ug | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIES | CS627867 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, papillary serous, metastatic from ORIGENE TECHNOLOGIES | CS713785 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, papillary serous from ORIGENE TECHNOLOGIES | CS637630 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, papillary serous, metastatic from ORIGENE TECHNOLOGIES | CS808360 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, papillary serous, metastatic from ORIGENE TECHNOLOGIES | CS807056 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, papillary serous, metastatic from ORIGENE TECHNOLOGIES | CS626107 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, papillary serous, metastatic from ORIGENE TECHNOLOGIES | CS545259 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS701980 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS704823 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS704824 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS707482 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS707481 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS707561 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS707562 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS701981 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS708226 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS708225 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS802825 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS802826 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS802827 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS803203 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS506931 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS506529 | 5x5um | ORIGENE TECHNOLOGIES |
| SET domain, bifurcated 1 (SETDB1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY402212 | 100 ug | ORIGENE TECHNOLOGIES |
| SET domain, bifurcated 2 (SETDB2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY432029 | 100 ug | ORIGENE TECHNOLOGIES |
| SET domain containing 1A (SETD1A) from ORIGENE TECHNOLOGIES | LY415047 | 100 ug | ORIGENE TECHNOLOGIES |
| Human Endometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS507904 | 5x5um | ORIGENE TECHNOLOGIES |
| SET domain containing (lysine methyltransferase) 7 (SETD7) from ORIGENE TECHNOLOGIES | LY403067 | 100 ug | ORIGENE TECHNOLOGIES |
| SET domain containing 3 (SETD3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY410259 | 100 ug | ORIGENE TECHNOLOGIES |
| SET domain containing 3 (SETD3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY404739 | 100 ug | ORIGENE TECHNOLOGIES |
| SET domain containing 4 (SETD4), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429534 | 100 ug | ORIGENE TECHNOLOGIES |